BLIS K12 Receives “No Objection” GRAS Letter From FDA

635914720924384696taste.jpg

19 Feb 2016 --- Oral-health probiotic BLIS K12 has received a “Letter of No Objection” from the US Food and Drink Administration (FDA) for its self-affirmed notification of Generally Recognized As Safe (GRAS) status.

The patented probiotic strain of Streptococcus salivarius, BLIS K12, has been studied for benefits to ear and throat health in children and adults, including reducing incidence of halitosis and Streptococal pharyngitis.
 
BLIS K12 developer Blis Technologies (Dunedin, New Zealand) and North America distributor Stratum Nutrition (Saint Charles, MO) celebrated the “No Objection” GRAS status as key to opening more markets for the probiotic:
 
“It adds a new level of credibility for BLIS K12 and puts the conversations with larger consumer food and beverage companies in the US on a stronger footing,” said Peter Fennessy, board chairman, Blis Technologies.
 
“Many of those companies are, quite rightly, risk averse. Therefore, having the non-objection notification from the FDA offers an additional level of confidence and makes it clearer where BLIS K12 fits within the category,” Fennessy added.
 
Jeremy Moore, managing director of Stratum Nutrition, added, “Very few ingredients in this space go to this level, so it is a definite feather in the cap for Blis.”
 
Through the GRAS program, companies may submit their determination, supported by research and expert review, that a specific ingredient is Generally Recognized As Safe. The Letter of No Objection means that the FDA has reviewed the data and has no questions regarding the notice submitted.

To contact our editorial team please email us at editorial@cnsmedia.com

Related Articles

Health & Nutrition News

ADM strengthens gut health strategy with US$235m Probiotics International acquisition

16 Aug 2018 --- Adding to a list of microbiome strategy investments, Archer Daniels Midland Company (ADM) has completed its acquisition of Probiotics International Limited (PIL) – known under its umbrella brand Protexin – in a US$235 million deal.

Health & Nutrition News

Microbe colonization study could inspire better probiotics, claim researchers

13 Aug 2018 --- A novel approach to identify the genes that may be important to help microbes live successfully in the human gut has been identified by a study published in PLOS Computational Biology. The approach utilizes a technique called phylogenetic linear modeling, which has often been used in ecology, but rarely in genomics. The researchers hope that the findings could be important for the development of new therapies to maintain or improve gut health, such as the design of better probiotics.

Health & Nutrition News

Weekly roundup: Lycored awarded for campaign, Support for probiotics in countering depression

10 Aug 2018 --- This week, Lycored was awarded for their innovative #rethinkbeautiful campaign and Good in Bloom initiative, while a new study supports the hypothesis that the modification of microbial ecology in human gut by supplementing probiotics may be an alternative strategy to ameliorate or prevent depression.

Health & Nutrition News

Premixes: Strong potential for plant-based nutritionals and protein innovation

07 Aug 2018 --- The aging of the population, increasing scientific evidence of the benefits of nutritional supplementation and the trend toward foods and beverages rather than pills and capsules have led to increased consumer interest in the incorporation of nutrient premixes to support a healthy diet. “Consumers are doing everything they can to stay healthy so that they can stay out of the traditional healthcare system,” says Sam Wright IV, CEO at The Wright Group, which develops custom nutrient premixes, the enrichment of rice and grains, as well as the microencapsulation of vitamins, minerals and omega 3.

Health & Nutrition News

Crickets can be good for the gut, claims new clinical trial

06 Aug 2018 --- Consuming crickets can help support the growth of beneficial gut bacteria and eating crickets is not only safe at high doses but may also reduce inflammation in the body, according to new research. "There is a lot of interest right now in edible insects," says lead author Valerie Stull. "It's gaining traction in Europe and in the U.S. as a sustainable, environmentally friendly protein source compared to traditional livestock."

More Articles
URL : http://www.nutritioninsight.com:80/news/blis-k12-receives-no-objection-gras-letter-from-fda.html